Adult Clinical Trials - Immunologic
Clinical Research
Michael Weller
Chairman
Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich
David Reardon
Clinical Director, Center for Neuro-Oncology
Dana-Farber/Harvard Cancer Center
Alba Brandes
AUSL–IRCCS Institute of Neurological Sciences
John Sampson
Chair Neurosurgery
Duke University Hospital
Paul Mulholland
University College London Hospitals
Antje Wick
University of Heidelberg, National Center for Tumor Diseases
Joachim Baehring
Yale School of Medicine
Manmeet Ahluwalia
Director Brain Metastases Research Program
Cleveland Clinic
Patrick Roth
Leading Physician
Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich
Oliver Bähr
Neurologische Klinik, Klinikum Aschaffenburg-Alzenau
Surasak Phuphanich
Barrow Neurological Institute
Juan Sepulveda
Hospital Universitario 12 de Octubre
Paul de Souza
University of Wollongong School of Medicine
Solmaz Sahebjam
Director of Clinical Research Unit, Leader of Moffitt Phase 1 Program, Director of Clinical Trials in Neuro-Oncology
Moffitt Cancer Center and Research Institute, University of South Florida
Von Potter
Bristol-Myers Squibb
Kay Tatsuoka
Bristol-Myers Squibb
Corina Taitt
Bristol-Myers Squibb
Ricardo Zwirtes
Bristol-Myers Squibb
Antonio Omuro
Department of Neurology and Yale Cancer Center, Yale University
Michael Lim
Professor
The Johns Hopkins Hospital